In the past 20 years, testicular cancer, which occurs in the young, has become a curable malignancy; 90% of the patients treated,vip achieve long-term survival, However, there is a significant morbidity associated with the management of the disease process, The literature was reviewed concerning the current treatment strategies and prognosis, as a ell as the long-term sequelae of the various diagnostic and therapeutic procedures, Surveillance has become a key element in the management of patients with a primary (stage I) testicular non-seminoma. Although approximately 25% of these patients will relapse, 100% survival can be achieved with cisplatin in combination with etoposide and bleomycin (BEP), Patients with a disseminated non-seminoma a...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer represents the most curable solid tumor, with a 10-year survival rate of more than...
In the past 20 years, testicular cancer, which occurs in the young, has become a curable malignancy;...
In the past 20 years, testicular cancer, which occurs in the young, has become a curable malignancy;...
Testicular cancer (TC) is the most frequent solid malignancy in young men aged between 15 and 40 yea...
Major advances have taken place in the overall management of patients with ali forms of testicular c...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
Germ cell tumors of the testes represent a unique paradigm of diseases which can be cured even in ex...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
To up-date the 2001 version of the EAU testicular cancer guidelines. A non-structured literature rev...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer represents the most curable solid tumor, with a 10-year survival rate of more than...
In the past 20 years, testicular cancer, which occurs in the young, has become a curable malignancy;...
In the past 20 years, testicular cancer, which occurs in the young, has become a curable malignancy;...
Testicular cancer (TC) is the most frequent solid malignancy in young men aged between 15 and 40 yea...
Major advances have taken place in the overall management of patients with ali forms of testicular c...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
Germ cell tumors of the testes represent a unique paradigm of diseases which can be cured even in ex...
Testicular cancer is the most common malignancy in men aged 15-35 years. Histologically, testicular ...
To up-date the 2001 version of the EAU testicular cancer guidelines. A non-structured literature rev...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer is a rare malignancy, however the most common malignancy in young men. Today, due ...
Testicular cancer represents the most curable solid tumor, with a 10-year survival rate of more than...